Check out our brand-new publication on “Quantification of evolved DNA-editing enzymes at scale with DEQSeq“. Congratulations to everyone involved! Related news 30. August 2024SaxoCell enters second phase of funding!Read More 30. April 2024Lukas Theo Schmitt honoured for his PhD thesis “Prediction of designer-recombinases for DNA editing with generative deep learning”Read More 24. April 2024Prof. Dr. Frank Buchholz receives Reinhart Koselleck grant for his project “Research into long-term epigenetic silencing modules to further develop the potential of therapeutic gene editing”Read More 8. March 2024Contributing with talk and posters to DG-GT’s 30th Annual Meeting in MunichRead More 31. January 2024New Nature paper from our lab on groundbreaking genome editing tools unlocking new possibilities for precision medicineRead More 18. January 2024Wirtschaftswoche “Start-up of the week”Read More 6. September 2023Frank Buchholz honoured for his commitment to transfer innovation from research to industryRead More 1. September 2023Frank Buchholz and Seamless Therapeutics GmbH on designer recombinases competing with CRISPRRead More 30. June 2023Laborjournal on Seamless TherapeuticsRead More 22. May 2023Jenna Hoersten represented the Buchholz Lab at the 26th ASGCT Annual Meeting in Los AngelesRead More
